Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPVG.L Regulatory News (PVG)

  • There is currently no data for PVG

Blocklisting Interim Review

3 Jun 2009 11:47

RNS Number : 2886T
Ark Therapeutics Group PLC
03 June 2009
 



Ark Therapeutics Group plc

3 June 2009 

BLOCKLISTING SIX MONTHLY RETURN

1.  Name of applicant

Ark Therapeutics Group plc

2.  Name of scheme

Ark Therapeutics Group Unapproved Share Option Scheme 

3.  Period of return

From 3/12/2008 - 2/06/2009

 

4. Balance of unallotted securities under scheme from previous return

 2,531,252

 

5. Plus: The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return (if any increase has been applied for)

 

Nil

6.  Less: Number of securities issued/allotted under the scheme during period

Nil

7.  Equals: Balance under the scheme not yet issued/allotted at end of period

2,531,252

BLOCKLISTING SIX MONTHLY RETURN

1.  Name of applicant

Ark Therapeutics Group plc

2.  Name of scheme

Ark Therapeutics Group Enterprise Management Incentive Share Option Plan 

3.  Period of return

From 3/12/2008 - 2/06/2009

 

4. Balance of unallotted securities under scheme from previous return

 

939,433

 

5. Plus: The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return (if any increase has been applied for)

 

Nil

6.  Less: Number of securities issued/allotted under the scheme during period

Nil

7.  Equals: Balance under the scheme not yet issued/allotted at end of period

939,433

BLOCKLISTING SIX MONTHLY RETURN

1.  Name of applicant

Ark Therapeutics Group plc

2.  Name of scheme

Ark Therapeutics Group 2005 Long Term Incentive Plan

3.  Period of return

From 3/12/2008 - 2/06/2009

 

4. Balance of unallotted securities under scheme from previous return

992,250

5. Plus: The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return (if any increase has been applied for)

Nil

6.  Less: Number of securities issued/allotted under the scheme during period

49,125

7.  Equals: Balance under the scheme not yet issued/allotted at end of period

943,125

BLOCKLISTING SIX MONTHLY RETURN

1.  Name of applicant

Ark Therapeutics Group plc

2.  Name of scheme

Ark Therapeutics Group Approved Share Option Plan

3.  Period of return

From 3/12/2008 - 2/06/2009

 

4. Balance of unallotted securities under scheme from previous return

1,000,000

 

5. Plus: The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return (if any increase has been applied for)

 

Nil

6.  Less: Number of securities issued/allotted under the scheme during period

Nil

7.  Equals: Balance under the scheme not yet issued/allotted at end of period

1,000,000

Name of contact: Martyn Williams, Company Secretary

Telephone number of contact: 0207 388 7722

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BLRDGGGVGFVGLZM
Date   Source Headline
6th Sep 20134:40 pmRNSSecond Price Monitoring Extn
6th Sep 20134:35 pmRNSPrice Monitoring Extension
6th Sep 201312:54 pmRNSHolding(s) in Company
4th Sep 20134:40 pmRNSSecond Price Monitoring Extn
4th Sep 20134:35 pmRNSPrice Monitoring Extension
2nd Sep 201312:00 pmRNSHolding(s) in Company
29th Aug 20134:41 pmRNSSecond Price Monitoring Extn
29th Aug 20134:35 pmRNSPrice Monitoring Extension
29th Aug 20139:00 amRNSHalf Yearly Report
16th Aug 20134:40 pmRNSSecond Price Monitoring Extn
16th Aug 20134:35 pmRNSPrice Monitoring Extension
15th Aug 20135:32 pmRNSHolding(s) in Company
14th Aug 20134:56 pmRNSHolding(s) in Company
30th Jul 20134:40 pmRNSSecond Price Monitoring Extn
30th Jul 20134:35 pmRNSPrice Monitoring Extension
23rd Jul 20133:44 pmRNSHolding(s) in Company
9th Jul 20132:00 pmRNSCompany Update
8th Jul 20134:40 pmRNSSecond Price Monitoring Extn
8th Jul 20134:35 pmRNSPrice Monitoring Extension
5th Jul 201310:48 amRNSHolding(s) in Company
5th Jul 20137:00 amRNSCompany Update
27th Jun 20134:40 pmRNSSecond Price Monitoring Extn
27th Jun 20134:35 pmRNSPrice Monitoring Extension
25th Jun 20132:05 pmRNSResults of Annual General Meeting
14th Jun 20134:40 pmRNSSecond Price Monitoring Extn
14th Jun 20134:35 pmRNSPrice Monitoring Extension
4th Jun 20132:48 pmRNSBlocklisting Six Monthly Return
24th May 20134:40 pmRNSSecond Price Monitoring Extn
24th May 20134:35 pmRNSPrice Monitoring Extension
17th May 20137:00 amRNSInterim Management Statement
16th May 20131:20 pmRNSHolding(s) in Company
8th May 20136:09 pmRNSHolding(s) in Company
8th May 20135:47 pmRNSHolding(s) in Company
2nd May 20131:45 pmRNSHolding(s) in Company
1st May 20134:35 pmRNSPrice Monitoring Extension
30th Apr 20137:00 amRNSFinal Results
26th Apr 20134:50 pmRNSHolding(s) in Company
24th Apr 20133:47 pmRNSHolding(s) in Company
26th Mar 20134:40 pmRNSSecond Price Monitoring Extn
26th Mar 20134:35 pmRNSPrice Monitoring Extension
22nd Mar 201311:50 amRNSHolding(s) in Company
20th Mar 20131:15 pmRNSHolding(s) in Company
19th Mar 201311:34 amRNSForm 8.3 - Ark Therapeutics
19th Mar 20139:47 amRNSHolding(s) in Company
18th Mar 20131:54 pmRNSForm 8.3 - Ark Therapeutics Group PLC
15th Mar 201312:01 pmRNSTermination of Offer Period and Rule 10.8 Waiver
7th Mar 20134:22 pmRNSForm 8.3 - [Ark Therapeutics Group]
6th Mar 20133:04 pmRNSForm 8.3 - [Ark Therapeutics Group]
6th Mar 201310:02 amRNSForm 8.3 - Ark Therapeutics Group Plc
1st Mar 201311:49 amRNSForm 8.3 - Ark Therapeutics

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.